In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
The role of intensive antiplatelet therapy for prevention of vascular events in patients with atrial fibrillation remains controversial.
This report from Garza et al describes improved outcomes in out-of-hospital cardiac arrest victims after a cardiopulmonary resuscitation (CPR) protocol change by the emergency medical services (EMS) system in Kansas City, MO.
